MedsForAll was founded with the vision to bring rescue drug autoinjectors to those who otherwise could not have afforded one.
The MedsForAll autoinjector can potentially utilize any medication that comes in a glass ampule and requires intramuscular delivery. Initially, our product will be compatible with epinephrine. Our product can provide an autoinjector to low resource settings that only have ampules. By designing our product separate from the drug it allows us to create the device at a lower cost than our competitors. Our patent pending device is the only epinephrine autoinjector that allows for replacement of the medication upon expiration, eliminating the need to replace the entire device. Our product also includes safety features, dose consistency, and ease of use to ensure anyone can safely administer the medication. Our autoinjector will eliminate the need for manual injections with ampules, decreasing time to treatment.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 3900 E Stevens Way Ne, Seattle,washington 98195,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- medsforallhealth.com
- HQ
- Seattle, Washington
Medsforall Questions
Medsforall's website is medsforallhealth.com
Medsforall's LinkedIn profile is https://www.linkedin.com/company/medsforall
Medsforall has
2 employees.
View email and phone details for 2
employees at Medsforall.
Medsforall's industry is
Biotechnology Research
Medsforall's top competitors are
Graycliff Partners Lp,
Selcouth Capital Management Lp,
Alliance Of Angels,
Aiche Northern California Local Section,
Sanisphere - A Poc Pharma Solution,
Januity Health,
Poc Pharma,
Openevidence,
Seachange Fund,
Truveta.
Medsforall's categories are Biotechnology Research
Medsforall's founding year is 2017
